EQS-Adhoc: LifeWatch AG: LifeWatch Services, Inc. to suspend Home Sleep Testing Services
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Miscellaneous
LifeWatch AG: LifeWatch Services, Inc. to suspend Home Sleep Testing Services
17.01.2016 / 19:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.
--------------------------------------------------------------------------------
LifeWatch Services, Inc. to suspend Home Sleep Testing Services
Zug/Switzerland, January 17, 2016 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services to the digital health market, announces that it has made a
business decision to suspend its current home sleep testing services while it
explores new innovations and options for providing a more efficient service to
its customers and patients. LifeWatch strongly believes in the value of home
sleep testing for patients in the cardiovascular space and looks forward to a
return to this business in the future.
LifeWatch has taken steps to ensure that customers continue to have a provider
for home sleep testing and will be informing customers accordingly.
For further questions:
LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Phone: +41 43 268 32 35 / +41 79 410 81 88
E-mail: investor-relations@lifewatch.com
About LifeWatch AG:
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote diagnostic
patient monitoring services. LifeWatch's services provide physicians with
critical information to determine appropriate treatment and thereby improve
patient outcomes. LifeWatch AG has operative subsidiaries in the United States,
in Switzerland and in Israel, and is the parent company of LifeWatch Services
Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading
U.S.-based provider of cardiac monitoring services and home sleep testing of
Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is
a leading developer and manufacturer of telemedicine products. For additional
information, please visitwww.lifewatch.com.
Sign upfor customized e-mail alerts and documentation requests at
http://www.irlifewatch.com/alert-service.aspx
This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position, the
business strategy, and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and long-term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
GENERAL
CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN
OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE
UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF
LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES
SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED
STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE
EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES
LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS
SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE
ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.
End of ad hoc announcement
+++++
Additional features:
Document:http://n.eqs.com/c/fncls.ssp?u=CTOCAPFFFJ
Document title: LifeWatch Services, Inc. to suspend Home Sleep Testing Services
--------------------------------------------------------------------------------
17.01.2016 News transmitted by EQS Schweiz AG. www.eqs.com - news archive:
http://switzerland.eqs.com/de/News
The issuer is responsible for the contents of the release.
--------------------------------------------------------------------------------
Language: English
Company: LifeWatch AG
Baarerstrasse 139
6300 Zug
Switzerland
Phone: +41 41 728 67 78
Internet: www.lifewatch.com
ISIN: CH0012815459
Valor: 811189
Listed: Regulated Unofficial Market in Berlin, Stuttgart; Open Market in
Frankfurt ; SIX
End of News EQS Group News Service
--------------------------------------------------------------------------------
429923 17.01.2016
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Agreement LifeWatch AG: Agreement with AliveCor, Inc. 11.01.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 428069 11.01.2016 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Regulatory Approval LifeWatch AG: CE marking for Mobile Cardiac Telemetry Patch 07.01.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 427423 07.01.2016 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Acquisition LifeWatch AG: Acquisition of FlexLife Health Inc., an INR monitoring company co-founded by the Cleveland Clinic 10.11.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this ...
plus
Ces informations peuvent également vous intéresser
Ces informations peuvent également vous intéresser